According to a new report by Polaris Market Research, the global Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics market was valued at USD 3.46 billion in 2025 and is projected to reach USD 6.97 billion by 2034, expanding at a CAGR of 8.1% over the forecast period. Growth is underpinned by rising adoption of immunotherapies, continued advancements in targeted therapies for...